With the rewilding of the Tasmanian tiger, Colossal Biosciences hopes to not only restore an apex marsupial ... As we inch closer to seeing this extinct predator return to the land it once roamed ...

While the idea of bringing back extinct species ... The return of the Tasmanian tiger may not be as far off as we once ...

New footage showing what is being claimed to be an extinct Tasmanian tiger in the wild has attracted ... The photographer, ...

The Tasmanian tiger ... "Many people, however, believe that bounty hunting alone could not have driven the thylacine extinct and therefore claim that an unknown disease epidemic must have been ...

Scientists are on the brink of reviving the Tasmanian tiger ... Tasmanian devil population. Not all scientists are on board with the idea. Some fear that reviving extinct species could have ...

American Startup Raises $200 Million to Resurrect Mammoth On the surface, it appears that the plan is set in stone. Following ...

Colossal Biosciences, the biotech company behind plans to try to bring back the woolly mammoth, Tasmanian tiger and the dodo, raised another $200 million for its research.

Colossal Biosciences is now valued at over $10 billion and is working on ambitious projects to resurrect multiple long ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Colossal Biosciences wants to bring back the woolly mammoth and has raised $200 million at a $10.2 billion valuation to do it.